Hollsteen
← Salesforce

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $222M · 10-Q 0001108524-15-000014 filed May 22, 2015Research and development · Q2 FY2016: $234M · 10-Q 0001108524-15-000025 filed Aug 25, 2015Research and development · Q3 FY2016: $239M · 10-Q 0001108524-15-000034 filed Nov 20, 2015Research and development · Q4 FY2016: $251M · derived · 10-K 0001108524-17-000006 filed Mar 6, 2017Research and development · Q1 FY2017: $261M · 10-Q 0001108524-16-000066 filed May 20, 2016Research and development · Q2 FY2017: $292M · 10-Q 0001108524-16-000085 filed Sep 1, 2016Research and development · Q3 FY2017: $311M · 10-Q 0001108524-16-000128 filed Nov 21, 2016Research and development · Q4 FY2017: $344M · derived · 10-K 0001108524-18-000011 filed Mar 9, 2018Research and development · Q1 FY2018: $376M · 10-Q 0001108524-17-000012 filed May 22, 2017Research and development · Q2 FY2018: $386M · 10-Q 0001108524-17-000020 filed Aug 25, 2017Research and development · Q3 FY2018: $394M · 10-Q 0001108524-17-000040 filed Nov 22, 2017Research and development · Q4 FY2018: $396M · derived · 10-K 0001108524-19-000009 filed Mar 8, 2019Research and development · Q1 FY2019: $424M · 10-Q 0001108524-18-000035 filed May 31, 2018Research and development · Q2 FY2019: $463M · 10-Q 0001108524-18-000057 filed Aug 31, 2018Research and development · Q3 FY2019: $481M · 10-Q 0001108524-18-000087 filed Nov 28, 2018Research and development · Q4 FY2019: $518M · derived · 10-K 0001108524-20-000014 filed Mar 5, 2020Research and development · Q1 FY2020: $554M · 10-Q 0001108524-19-000025 filed Jun 5, 2019Research and development · Q2 FY2020: $607M · 10-Q 0001108524-19-000052 filed Aug 23, 2019Research and development · Q3 FY2020: $774M · 10-Q 0001108524-19-000076 filed Dec 4, 2019Research and development · Q4 FY2020: $831M · derived · 10-K 0001108524-22-000008 filed Mar 17, 2021Research and development · Q1 FY2021: $859M · 10-Q 0001108524-22-000007 filed Jun 1, 2020Research and development · Q2 FY2021: $898M · 10-Q 0001108524-20-000041 filed Aug 28, 2020Research and development · Q3 FY2021: $902M · 10-Q 0001108524-20-000047 filed Dec 4, 2020Research and development · Q4 FY2021: $939M · derived · 10-K 0001108524-22-000013 filed Mar 11, 2022Research and development · Q1 FY2022: $951M · 10-Q 0001108524-21-000030 filed Jun 2, 2021Research and development · Q2 FY2022: $1.0B · 10-Q 0001108524-21-000047 filed Aug 27, 2021Research and development · Q3 FY2022: $1.2B · 10-Q 0001108524-21-000055 filed Dec 2, 2021Research and development · Q4 FY2022: $1.3B · derived · 10-K 0001108524-23-000011 filed Mar 8, 2023Research and development · Q1 FY2023: $1.3B · 10-Q 0001108524-22-000022 filed Jun 1, 2022Research and development · Q2 FY2023: $1.3B · 10-Q 0001108524-22-000041 filed Aug 25, 2022Research and development · Q3 FY2023: $1.3B · 10-Q 0001108524-22-000060 filed Dec 1, 2022Research and development · Q4 FY2023: $1.1B · derived · 10-K 0001108524-24-000005 filed Mar 6, 2024Research and development · Q1 FY2024: $1.2B · 10-Q 0001108524-23-000023 filed Jun 1, 2023Research and development · Q2 FY2024: $1.2B · 10-Q 0001108524-23-000040 filed Aug 31, 2023Research and development · Q3 FY2024: $1.2B · 10-Q 0001108524-23-000048 filed Nov 30, 2023Research and development · Q4 FY2024: $1.3B · derived · 10-K 0001108524-25-000006 filed Mar 5, 2025Research and development · Q1 FY2025: $1.4B · 10-Q 0001108524-24-000009 filed May 30, 2024Research and development · Q2 FY2025: $1.3B · 10-Q 0001108524-24-000022 filed Aug 29, 2024Research and development · Q3 FY2025: $1.4B · 10-Q 0001108524-24-000034 filed Dec 4, 2024Research and development · Q4 FY2025: $1.4B · derived · 10-K 0001108524-26-000060 filed Mar 2, 2026Research and development · Q1 FY2026: $1.5B · 10-Q 0001108524-25-000030 filed May 29, 2025Research and development · Q2 FY2026: $1.5B · 10-Q 0001108524-25-000088 filed Sep 4, 2025Research and development · Q3 FY2026: $1.4B · 10-Q 0001108524-25-000238 filed Dec 4, 2025Research and development · Q4 FY2026: $1.6B · derived · 10-K 0001108524-26-000060 filed Mar 2, 2026Research and development · Q1 FY2027: $1.6B · 10-Q 0001108524-26-000127 filed May 28, 2026Research and development · Q2 FY2027: $1.7B · 10-Q 0001108524-26-000190 filed Aug 27, 2026939a1,687222Q1 FY2016Q2 FY2027Q4 FY2021
$MResearch and development · Q4 FY2020: $831M · derived · 10-K 0001108524-22-000008 filed Mar 17, 2021Research and development · Q1 FY2021: $859M · 10-Q 0001108524-22-000007 filed Jun 1, 2020Research and development · Q2 FY2021: $898M · 10-Q 0001108524-20-000041 filed Aug 28, 2020Research and development · Q3 FY2021: $902M · 10-Q 0001108524-20-000047 filed Dec 4, 2020Research and development · Q4 FY2021: $939M · derived · 10-K 0001108524-22-000013 filed Mar 11, 2022Research and development · Q1 FY2022: $951M · 10-Q 0001108524-21-000030 filed Jun 2, 2021Research and development · Q2 FY2022: $1.0B · 10-Q 0001108524-21-000047 filed Aug 27, 2021Research and development · Q3 FY2022: $1.2B · 10-Q 0001108524-21-000055 filed Dec 2, 2021939a1,203831aQ4 FY2020Q3 FY2022Q4 FY2021
Q4 FY2021
939a$M
derived
All values (46)
PeriodValue ($M)Status
Q2 FY20271,687reported
Q1 FY20271,627reported
Q4 FY20261,619derived
Q3 FY20261,433reported
Q2 FY20261,481reported
Q1 FY20261,460reported
Q4 FY20251,420derived
Q3 FY20251,356reported
Q2 FY20251,349reported
Q1 FY20251,368reported
Q4 FY20241,275derived
Q3 FY20241,204reported
Q2 FY20241,220reported
Q1 FY20241,207reported
Q4 FY20231,128derived
Q3 FY20231,280reported
Q2 FY20231,329reported
Q1 FY20231,318reported
Q4 FY20221,291derived
Q3 FY20221,203reported
Q2 FY20221,020reported
Q1 FY2022951reported
Q4 FY2021939derived
Q3 FY2021902reported
Q2 FY2021898reported
Q1 FY2021859reported
Q4 FY2020831derived
Q3 FY2020774reported
Q2 FY2020607reported
Q1 FY2020554reported
Q4 FY2019518derived
Q3 FY2019481reported
Q2 FY2019463reported
Q1 FY2019424reported
Q4 FY2018396derived
Q3 FY2018394reported
Q2 FY2018386reported
Q1 FY2018376reported
Q4 FY2017344derived
Q3 FY2017311reported
Q2 FY2017292reported
Q1 FY2017261reported
Q4 FY2016251derived
Q3 FY2016239reported
Q2 FY2016234reported
Q1 FY2016222reported

CSV with all sources · Technical ID: rnd

More metrics for Salesforce

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$939M (derived)
Period
Q4 FY2021, ended Jan 31, 2021 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 3,598M − 2,659M = $939M (FY value from 10-K 0001108524-22-000013; 9-month value from the Q3-10-Q)
Source
10-K, filed Mar 11, 2022 · 0001108524-22-000013
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$939MMar 11, 202210-K 0001108524-22-000013derived · confidence 1. · current